Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded Beijing Municipality under Locations and updated the location labeling; added Snyder et al. 2014 NEJM citation to Publications, while removing the previous Beijing Municipality Locations entry and its related Erratum citation.SummaryDifference0.3%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedPublications section updated to clarify that publications are provided voluntarily by contributors who enter information about the study results, and the site revision badges were updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check37 days agoChange DetectedPublications section updated: a 2014 NEJM paper on CTLA-4 blockade was added with erratum details, and the previous citation entry was removed.SummaryDifference0.4%

- Check59 days agoChange DetectedThe two screenshots show the same Study Details page with identical trial information (title, conditions, eligibility criteria, interventions, outcomes, and locations). No core content or data elements were added or removed.SummaryDifference0.4%

- Check81 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. The page now communicates operating status details and a newer software version.SummaryDifference2%

- Check88 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; core page metadata updated to reflect a new release.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.